Molecular profile of follicular tumors of the thyroid gland

More than 90 % of newly diagnosed cases endocrine cancer occur in the thyroid gland. Introduction fine needle puncture gland, with classification cytological material according to Bethesda system, has become cornerstone diagnosis malignant neoplasms However, traditionally this there remains a weak link called follicular tumor (category IV). The detection does not allow one reliably classify mass as benign or and requires surgical intervention morphological verification. In recent years, possibilities molecular genetic testing have improved markedly. Follicular tumors tend accumulate mutations, which over time can lead transformation, but also be used method timely diagnosis. This review analyzes literature on assessing potential formations